These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells. Pardee AD; Shi J; Butterfield LH J Immunol; 2014 Dec; 193(11):5723-32. PubMed ID: 25355916 [TBL] [Abstract][Full Text] [Related]
3. AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients. Evdokimova VN; Liu Y; Potter DM; Butterfield LH J Immunother; 2007; 30(4):425-37. PubMed ID: 17457217 [TBL] [Abstract][Full Text] [Related]
4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
8. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401 [TBL] [Abstract][Full Text] [Related]
9. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells. Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295 [TBL] [Abstract][Full Text] [Related]
10. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma. Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma. Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875 [TBL] [Abstract][Full Text] [Related]
12. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200 [TBL] [Abstract][Full Text] [Related]
13. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma. Ritter M; Ali MY; Grimm CF; Weth R; Mohr L; Bocher WO; Endrulat K; Wedemeyer H; Blum HE; Geissler M J Hepatol; 2004 Dec; 41(6):999-1007. PubMed ID: 15582134 [TBL] [Abstract][Full Text] [Related]
14. Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. Butterfield LH; Economou JS; Gamblin TC; Geller DA J Transl Med; 2014 Apr; 12():86. PubMed ID: 24708667 [TBL] [Abstract][Full Text] [Related]
15. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448 [TBL] [Abstract][Full Text] [Related]
16. Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. Ayaru L; Pereira SP; Alisa A; Pathan AA; Williams R; Davidson B; Burroughs AK; Meyer T; Behboudi S J Immunol; 2007 Feb; 178(3):1914-22. PubMed ID: 17237442 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor immunity elicited by cross-linking vaccine heat shock protein 72 and alpha-fetoprotein epitope peptide. Li Z; Wang XP; Lin HP; Xu B; Zhao Q; Qi BN; Yang YX; Wang ZR Neoplasma; 2015; 62(5):713-21. PubMed ID: 26278150 [TBL] [Abstract][Full Text] [Related]
18. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells. Zhang HM; Zhang LW; Ren J; Fan L; Si XM; Liu WC Cell Immunol; 2006 Feb; 239(2):144-50. PubMed ID: 16814271 [TBL] [Abstract][Full Text] [Related]
19. Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma. Vogt A; Sadeghlar F; Ayub TH; Schneider C; Möhring C; Zhou T; Mahn R; Bartels A; Praktiknjo M; Kornek MT; Toma M; Schmidt-Wolf IGH; Branchi V; Matthaei H; Kalff JC; Strassburg CP; Gonzalez-Carmona MA Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282787 [TBL] [Abstract][Full Text] [Related]
20. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. Mizukoshi E; Nakamoto Y; Tsuji H; Yamashita T; Kaneko S Int J Cancer; 2006 Mar; 118(5):1194-204. PubMed ID: 16152611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]